UBS reiterates Buy on TD Synnex stock, cites hyperscaler strength By Investing.com

TD Synnex reported Q4 2026 revenue of $17.4B, up 10% YoY, and non-GAAP diluted EPS of $3.83, up 24% YoY. UBS reiterated a Buy with a $193 price target (stock at $161.95, P/E 16.5, PEG 0.64), while Goldman raised its target to $180 and Morgan Stanley to $174; RBC reiterated Outperform citing strong billings and PC/AI-PC demand. Management/industry checks point to Hyve momentum from hyperscalers, Windows 11 refresh and DRAM/NAND tightness supporting near-term upside; market cap is ~$13B and shares are up ~31% over the past year.

Analysis

SNX is positioned to capture a near-term squeeze between hyperscaler capex and enterprise refresh cycles, which amplifies billings volatility and short-term cash conversion swings. The non-obvious winner from that dynamic are upstream memory and storage OEMs that can flex production into hyperscaler windows, but that also raises working-capital financing needs for distributors and increases counterparty concentration risk if one large buyer re-times orders.

A key near-term catalyst is the cadence of hyperscaler orders over the next 2-6 quarters: sustained multi-quarter follow-through would drive outsized EPS conversion and justify multiple expansion, while a single quarter pause could force inventory write-downs and margin compression within 90 days. Over 12-24 months, normalization of DRAM/NAND supply and the natural taper of a Windows-driven refresh represent the primary reversal vectors — both would hit billings growth first and reported revenue second.

Consensus appears to under-price concentration and timing risk: analyst multiple expansion assumes steady top-line momentum and stable margins, not episodic hyperscaler billings. That makes a calibrated trade attractive — capture upside from contract-driven acceleration while keeping explicit hedges for capex cadence or component supply normalization that could erase 20–30% of implied upside within a single quarter.

Key Decisions for Investors

• Long SNX equity (6–12 months): buy SNX to capture Hyve/hyperscaler momentum with a target +25% and a hard stop at -12%; size as 2–4% portfolio tail to reflect execution and concentration risk.
• Relative trade (6 months): pair long SNX / short ARW 1:1 to isolate distributor exposure to hyperscalers vs broader enterprise distribution; target 10–15% relative outperformance, stop if spread widens >8% against you.
• Option spread (9–15 months): buy a 12–15 month SNX call spread ~5–20% OTM (debit-limited downside) to play multiple expansion; aim for 2.5x+ payoff if billings stay elevated, max loss = premium paid.
• Hedge (3 months): buy short-dated put protection on SNX or overlay a short position in a memory supplier (MU) sized to cover 50% of position P&L for the first quarter, as a hedge against a sudden DRAM/NAND supply normalization that would reverse the PC/Hyve tailwind.